FindTrial
Sign In

Establishment of Biorepository for Adverse Drug Reaction Research

Establishment of Biorepository for Adverse Drug Reaction Research

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000428
Enrollment
100
Registered
2012-04-30
Start date
2012-03-05
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Ajou University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Positive response to Lys-ASA BPT; =20% decrease in FEV1 (post challenge FEV1 -pre-challenge FEV1) followed for 7 hours after the final dose of ASA challenge * Positive result on an ASA OPT; skin reaction occurs after ASA ingestion

Exclusion criteria

Exclusion criteria: Delayed hypersensitivity to aspirin

Design outcomes

Primary

MeasureTime frame
Identification of genetic risk factor for NSAID hypersensitivity—

Secondary

MeasureTime frame
Genetic biomarker of NSAID hypersensitivity—

Countries

Korea, Republic of

Contacts

Public Contactseung hyun kim

Ajou University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026